Recent breakthroughs in machine learning and artificial intelligence have uncovered significant benefits for health economics and outcomes research.
🔍 Discover the transformative power of AI in HEOR in our latest blog: https://t.co/ozAMsrdrou
#AI#HEOR#RWE
Challenges launching inflammatory disease treatments require creative solutions. We describe 3 common issues & how they were overcome, leading to submission success:
✅ The crowded marketplace
✅ The #raredisease indication
✅ Leveraging #realworldevidence
https://t.co/MzVsolrZjJ
Have you experienced the unique challenges faced with getting an inflammatory disease treatment to market? We’re excited to invite you to our upcoming Office Hours!
Register here: https://t.co/8I0NuAW5xz
#InflammatoryDiseases#RWA#HEOR#HTA
Join us at Booth #1023 at #ISPORAnnual to learn how our experts can help you make confident development decisions. Book a meeting today: https://t.co/rlruGUQ38m #ISPORAnnual
Hot off the press!
Do solid tumors undergo spontaneous regression?
Can placebo alone produce response in solid tumors?
We attempt to answer this question in this new study published @eClinicalMed : https://t.co/7RpfL2IknR